XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,468,911 | -9.2% | 716,303 | +2.3% | 0.01% | 0.0% |
| Q2 2023 | $26,949,423 | +4471.6% | 699,985 | +4149.8% | 0.01% | – |
| Q1 2023 | $589,497 | -90.3% | 16,471 | -91.7% | 0.00% | -100.0% |
| Q1 2022 | $6,074,000 | -33.9% | 198,701 | -32.4% | 0.00% | 0.0% |
| Q4 2021 | $9,187,000 | +5536.2% | 294,100 | +2269.9% | 0.00% | – |
| Q4 2019 | $163,000 | +71.6% | 12,410 | +17.7% | 0.00% | – |
| Q3 2019 | $95,000 | -30.7% | 10,545 | -23.9% | 0.00% | – |
| Q2 2019 | $137,000 | – | 13,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |